✦ LIBER ✦

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer

Book ID: 123162333
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 290 KB
Volume: 12
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(95)98908-S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of a 75-mg/m2 dose of doc

✍ Vincent A. Miller; James R. Rigas; Prudence A. Francis; Stefan C. Grant; Katheri 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

## Background. A prior Phase I1 study of a 100-mg/m2 dose of docetaxel conducted at the Memorial Sloan-Kettering Cancer Center (New York, NY) demonstrated a 38% response rate with grade 3 or 4 neutropenia in 76% of the patients and a grade 2 or greater rash or infusionrelated reaction in 41% and 3

Consecutive phase II trials of docetaxel

Consecutive phase II trials of docetaxel (taxotere®) 100 MG/M2 and 75 MG/M2 with prednisone in patients with stage IIIB and IV non-small cell lung cancer

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Phase II trial of docetaxel with dexamet

Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer: the Canadian experience

✍ J. Latreille; K.A. Gelmon; V. Hirsh; F. Laberge; A.W. Maksymiuk; F.A. Shepherd; 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 64 KB

147 Phase II studies of a 60 mg/m2 dose

147 Phase II studies of a 60 mg/m2 dose of docetaxel in patients with non-small cell lung cancer

✍ Hiraki, S.; Watanabe, K.; Furuse, K.; Kudo, S.; Ohnoshi, T.; Niitani, H. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 157 KB

A phase II trial of low-dose docetaxel (

A phase II trial of low-dose docetaxel (DCT) 60 mg/m2 in platinum-pretreated advanced non-small cell lung cancer (NSCLC)

✍ Kusaba, H; Nakamura, Y; Kunitoh, H; Sekine, I; Kubota, K; Tamura, T; Shinkai, T; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 120 KB

46 A phase II trial of biweekly docetaxe

46 A phase II trial of biweekly docetaxel combined with carboplatinfor patients with advanced non-small cell lung cancer

✍ Ishimoto, O.; Sugawara, S.; Inoue, A.; Ishida, T.; Koinumaru, S.; Haseaawa, Y.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB